📰 Molecular Diagnostics Program Mol News

Molecular Diagnostics Program Mol News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Molecular Diagnostics Program Mol. Real-time updates on events, politics, business and more.

Foundation Medicine and Natera Announce Broad Clinical Launch and Medicare Coverage of FoundationOneTracker

October 11, 2023

CAMBRIDGE - Foundation Medicine, Inc., and Natera, Inc., today announced the broad clinical launch of FoundationOneTracker, a personalized tissue-informed circulating tumor DNA test to monitor...

United States New York San Carlos United Kingdom Brian Alexander Abigail Alderman

Source: marketscreener.com

Global Minimal Residual Disease (MRD) Testing Markets 2021-2027: Potential Long-Term Cost Savings / Increasing Market Access in Emerging Economies / Technological Evolution of Testing

June 23, 2022

/PRNewswire/ -- The "Global MRD Testing Market: Focus on Technology, Application, End User, Region - Analysis and Forecast, 2022-2027" report has been added to...

United States Inivata Invisionfirst Laura Wood Natera Inc Guardant Health Quest Diagnostics Incorporated

Source: prnewswire.com

Global Minimal Residual Disease (MRD) Testing Market

June 22, 2022

Dublin, June 22, 2022 (GLOBE NEWSWIRE) -- The "Global MRD Testing Market: Focus on Technology, Application, End User, Region - Analysis and Forecast,...

United States Roche Ltd Bio Rad Laboratories Inc Guardant Health National Cancer Institute Adaptive Biotechnologies Corporation

Source: globenewswire.com

NephroSant Publishes Real-World Evidence Showing Potential to Improve the Detection of Early Rejection Events with QSant

March 3, 2022

/PRNewswire/ -- NephroSant™ a biotechnology company dedicated to accelerating the diagnosis of early kidney damage in native and transplanted kidneys, with a...

Minnie Sarwal Brian Talbert Gina Ford Centers For Medicare Medicaid Services Nephrosant Early Access Program Laboratory Developed Test